A
$ Value
$0
Shares
10,417
Price
$0
Filed
Oct 7
Insider
Name
D'Silva Andrew J.
Title
Chief Business Officer
CIK
0002083717
Roles
Officer
Transaction Details
Transaction Date
2025-08-21
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
47,514
Footnotes
Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date. | The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.